Yahoo India Web Search

Search results

  1. People also ask

  2. Nov 16, 2023 · Dr Rashid Kazmi, Honorary Senior Lecturer at the University of Southampton and Consultant Haematologist at University Hospital Southampton, said: “We welcome the MHRA’s authorisation of this innovative new treatment for sickle-cell disease and transfusion-dependent β-thalassemia in patients aged 12 and over.

  3. Jul 28, 2023 · A pioneering treatment, which effectively cures the blood clotting disorder haemophilia A, has been approved for use in the USA. This landmark moment comes after years of research. The lead for this in Southampton is Dr Rashid Kazmi.

  4. Dr. Rashid Kazmi. Dr Kazmi is a consultant haematologist and Director of Haemostasis and Thrombosis Centre at University Hospital Southampton. He established the coagulation medicine Services to achieve the status of Haemophilia Comprehensive Care Centre in 2007 with full accreditation by the European Association for Haemophilia and Allied ...

  5. Dec 15, 2022 · A pioneering new treatment for the blood clotting disorder haemophilia B, developed in a trial led by Southampton’s Dr Rashid Kazmi, has been approved in the USA.

  6. ‪University Hospital Southampton‬ - ‪‪Cited by 1,755‬‬ - ‪Haemostasis and Thrombosis‬

  7. Rashid Kazmi's 23 research works with 893 citations and 7,446 reads, including: Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B

  8. Rashid KAZMI, Consultant Haematologist, Director Haemostasis and Thrombosis Centre | Cited by 373 | of University Hospital Southampton NHS Foundation Trust, Southampton | Read 23...